Results 91 to 100 of about 559,125 (302)

Interpreting the effects of DNA polymerase variants at the structural level

open access: yesMolecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi   +7 more
wiley   +1 more source

Clustering with Niching Genetic K-means Algorithm

open access: yes, 2004
GA-based clustering algorithms often employ either simple GA, steady state GA or their variants and fail to consistently and efficiently identify high quality solutions (best known optima) of given clustering problems, which involve large data sets with ...
Liu, X   +8 more
core   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

Self-Adaptive K-Means Based on a Covering Algorithm

open access: yesComplexity, 2018
The K-means algorithm is one of the ten classic algorithms in the area of data mining and has been studied by researchers in numerous fields for a long time.
Yiwen Zhang   +6 more
doaj   +1 more source

RACK: RApid Clustering using K-means algorithm

open access: yes, 2009
The k-means algorithm is an extremely popular technique for clustering data. One of the major limitations of the k-means is that the time to cluster a given dataset D is linear in the number of clusters, k.
Murty, MN, Garg, Vikas K
core  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Improvement of Differential Privacy K-means Clustering Algorithm

open access: yesJournal of Harbin University of Science and Technology
In order to address the issues of arbitrary center selection and unreasonable privacy budget allocation leading to poor clustering performance in differential privacy K-means clustering algorithm, a new center selection scheme is designed based on two ...
GUO Rumin, CHEN Xuebin, SHAN Liyang
doaj   +1 more source

Improved point center algorithm for K-Means clustering to increase software defect prediction

open access: yesIJAIN (International Journal of Advances in Intelligent Informatics), 2020
The k-means is a clustering algorithm that is often and easy to use. This algorithm is susceptible to randomly chosen centroid points so that it cannot produce optimal results.
Riski Annisa, Didi Rosiyadi, Dwiza Riana
doaj   +1 more source

Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis

open access: yesMolecular Oncology, EarlyView.
This schematic outlines the workflow from biomarker identification to duplex MethyLight assay validation for epithelial ovarian cancer diagnosis using cfDNA‐based liquid biopsy. Initial screening of hypermethylated CpG candidates (cg02957270, cg10061138 cg00480298, COL2A1) was performed in tissue using ARMS‐PCR, COBRA, qPCR and image analysis. Selected
Deepa Bisht   +3 more
wiley   +1 more source

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

open access: yesMolecular Oncology, EarlyView.
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy